INmune Bio Inc. - Common stock (INMB) analyst actions
Rating and price-target actions on INMB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the INMB overview →
1 measured INMB analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer | Press release | -0.46% | +3.34% |
Keep exploring
More INMB: earnings → · SEC filings → · INMB overview →